mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK

Mammalian target of rapamycin complex 1 (mTORC1) inhibitors are extensively used as immunosuppressants to prevent transplant rejection and in treatment of certain cancers. In patients, chronic treatment with rapamycin or its analogues (rapalogues) has been reported to lead to sensory hypersensitivit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Melemedjian, Ohannes K., Khoutorsky, Arkady, Sorge, Robert E., Yan, Jin, Asiedu, Marina N., Valdez, Arely, Ghosh, Sourav, Dussor, Gregory, Mogil, Jeffrey S., Sonenberg, Nahum, Price, Theodore J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742001/
https://ncbi.nlm.nih.gov/pubmed/23607966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pain.2013.03.021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky